Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
NCT00974051
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
Terbutaline
OTHER:
20% basal insulin reduction
OTHER:
Control
Sponsor
University of Colorado, Denver